Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
10 studies found for:    7165009 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Withdrawn Endoscopic Ultrasound-guided Celiac Plexus Neurolysis in the Management of Pain in Abdominal Non-pancreatic Malignancies
Conditions: Pain;   Cancer
Intervention: Procedure: EUS-guided Celiac Plexus Neurolysis
2 Recruiting iMRI-guided Brain Biopsies
Condition: Supratentorial Brain Tumour
Interventions: Device: Stereotactic intraoperative magnetic resonance (iMRI)-guided frameless brain tumour biopsy;   Device: Stereotactic frameless brain tumour biopsy
3 Completed
Has Results 		A Study for Patients With Recurrent or Metastatic Squamous Cell Head and Neck Cancer
Condition: Head and Neck Neoplasms
Interventions: Drug: Pemetrexed;   Drug: Cetuximab;   Drug: Cisplatin;   Dietary Supplement: Folic Acid;   Dietary Supplement: Vitamin B12
4 Completed The Clinical Outcomes of the Percutaneous Cholecystostomy, Supportive Care Versus Cholecystectomy.
Conditions: Acute Calculous Cholecystitis;   Acute Acalculous Cholecystitis
Intervention:
5 Not yet recruiting A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung
Condition: Carcinoma of the Lung.
Interventions: Drug: Binimetinib;   Drug: Pemetrexed;   Drug: Carboplatin
6 Active, not recruiting 1st-line Activity of Dovitinib and Correlation With Genetic Changes in RCC
Condition: Clear Cell Renal Cell Carcinoma
Intervention: Drug: Dovitinib
7 Recruiting A Multi-Centre Phase II Study Using Carboplatin AUC-10 for Metastatic Seminoma With IGCCCG Good Prognosis Disease-Therapy Directed by Initial Metabolic Response on PET-CT
Condition: Metastatic Seminoma
Intervention: Drug: Carboplatin AUC-10
8 Completed Study to Investigate the Absorption, Distribution, Metabolism and Elimination of [14C]GSK1120212
Conditions: Solid Tumours;   Cancer
Intervention: Drug: GSK1120212
9 Recruiting Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)
Conditions: Adult Women;   Metastatic Breast Cancer;   Estrogen Receptor Positive
Intervention: Drug: Cholecalciferol
10 Terminated Anidulafungin in Patients With Hematologic Malignancies
Condition: Hematologic Malignancies
Intervention: Drug: Anidulafungin
To Top

† Indicates status has not been verified in more than two years